The gene synthesis market market has seen considerable growth due to a variety of factors.
•The value of the gene synthesis industry has expanded swiftly in the previous few years. Its worth is expected to increase from $3.32 billion in 2024 to $3.98 billion in 2025, with a compound annual growth rate (CAGR) of 19.7%.
The remarkable growth during the past years is thought to be due to enhancements in genetic studies, the emergence of personalized medicine, an increasing emphasis on biotechnology, expansion in the biopharmaceutical field, and the development of technology platforms for synthesis.
The gene synthesis market market is expected to maintain its strong growth trajectory in upcoming years.
• The expected increase in the gene synthesis market size over the coming years is projected to be significant. This market is anticipated to expand up to "$8.67 billion by 2029, with a compound annual growth rate (CAGR) of 21.5%.
This predicted surge during the forecast period can be attributed to several factors. These include the rapid evolution of synthetic biology, the rise of CRISPR technology, a growing demand for custom genes, developments in gene editing and therapy, and the broadening use in agricultural applications. Key trends during this period are likely to include more accessible pricing, custom gene libraries targeting functional genomics, automation, high-throughput synthesis, partnerships within the biotechnology and pharmaceutical industries, and an enhanced emphasis on ethical and regulatory concerns.
Anticipated growth in the gene synthesis market can be tethered to the escalating prevalence of chronic infectious diseases. These diseases, caused by pathogens that inhabit the body over extended periods, can be tackled effectively with gene synthesis. Through this process, the creation of new vaccines, diagnostics, and specific therapeutics that target specific pathogens becomes possible. This method is quicker and more precise than conventional ones and is capable of managing infectious disease outbreaks. Drawing an example, the World Health Organization, stationed in Switzerland, released data in November 2023 estimating that 10.6 million people, including 5.8 million men, 3.5 million women, and 1.3 million children, globally developed tuberculosis (TB) in 2022. As a result, the mounting prevalence of chronic infectious diseases catalyzes the expansion of the gene synthesis market.
The gene synthesis market market covered in this report is segmented –
1) By Method: Solid-Phase Synthesis, Chip-Based Synthesis, PR-Based Enzyme Synthesis
2) By Service: Antibody DNA Synthesis, Viral DNA Synthesis, Other Services
3) By Application: Gene And Cell Therapy Development, Vaccine Development, Disease Diagnosis, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Contract Research Organizations
Subsegments:
1) By Solid-Phase Synthesis: Phosphoramidite Method, H-phosphonate Method
2) By Chip-Based Synthesis: Microarray Technology, Light-Directed Synthesis
3) By PCR-Based Enzyme Synthesis: Polymerase Chain Reaction (PCR), Reverse Transcription PCR (RT-PCR)
The primary trends gaining traction in the gene synthesis industry are technological advancements. In order to maintain their prominence in the market, various companies in this sector are integrating new technologies into their operations. For instance, in June 2024, the US-based biotechnology firm, GenScript Biotech Corporation, rolled out the FLASH Gene service. This innovative service, an ultra-fast sequence-to-plasmid (S2P) service, was created to address the increasing need for swift gene synthesis and plasmid preparation. This updated offering enables researchers to acquire their plasmid constructs within a span of only four business days, which is considerably quicker than conventional techniques.
Major companies operating in the gene synthesis market market include:
• Genscript Biotech Corporation
• Brooks Automation Inc.
• Boster Biological Technology Ltd.
• Twist Bioscience Corp.
• ProteoGenix Inc.
• Biomatik Corporation
• ProMab Biotechnologies Inc.
• Thermo Fisher Scientific Inc.
• Integrated DNA Technologies Inc.
• OriGene Technologies Inc.
• GenScript Corp.
• Eurofins Scientific SE
• Merck KGaA
• Codex DNA Inc.
• Genewiz Inc.
• Eurofins Genomics LLC
• BioCat GmbH
• Bioneer Pacific Co. Ltd.
• Bio Basic Inc.
• Beijing SBS Genetech Co. Ltd
• Creative Biogene Inc
• Exonbio LLC.
• Trenzyme GmbH
• AddLife AB
• Polygen GmbH
• MACROGEN CO. LTD.
• Synbio Technologies LLC
North America was the largest region in the gene synthesis market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global gene synthesis market report during the forecast period. The regions covered in the gene synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa